register

Medical and Science

Females at higher levels of depression and anxiety from COVID-19, according to Monash University

Health Industry Hub | May 20, 2020 |

Medical News: Professor Jayashri Kulkarni, along with researchers from the Monash Alfred Psychiatry research centre (MAPrc) are currently conducting a nationwide survey tracking the mental health impacts of the COVID-19 pandemic on Australians.

The survey is ongoing and has already been completed by 2,000 Australians nationally – looking at both the mental health consequences of the pandemic and resilience factors that contribute to good mental health. Researchers will continue to follow the participants for two years and document their findings.

Preliminary Findings

  1. About 20% of Australian adult respondents are reporting moderate to severe levels of psychological impact of the COVID-19 pandemic.  
  2. Levels of depression, anxiety and stress are higher than what would normally be seen in the general population.
  3. Depression: 25% of the respondents reported moderate to severe levels of depression.
  4. Stress and anxiety: 14% reported moderate to severe levels of anxiety; and 19% reported moderate to severe levels of stress.  
  5. Females had higher levels of depression, anxiety and stress.  
  6. Poorer mental health outcomes are also associated with feelings of isolation and loneliness.  
  7. Poorer mental health outcomes were seen in people who had COVID-19 related loss of employment.  
  8. Between 3 April – 3 May, the psychological impact of the pandemic, including depression and anxiety symptoms was reported as moderate to severe in 35% of females compared to 19% of males for depression, 21% of females compared to 9% of males for anxiety. 
  9. Suicidal thoughts were reported in 17% of females and 14% of males.  

In alignment with the Federal Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to support Pharma, Biotech and MedTech industry professionals and supported by Medicines Australia, AusBiotech and ARCS Australia. Learn more.


News & Trends - Pharmaceuticals

Health Industry Hub is the only one-stop-hub bringing the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

If action isn’t needed now, then when?

Health Industry Hub | December 17, 2024 |

Tossing a pebble into a pond creates ripples that reach far beyond the initial splash. Every choice we make, every […]

More


News & Trends - Biotechnology

Victoria prioritises health technologies and medical research in economic growth statement

Victoria prioritises health technologies and medical research in economic growth statement

Health Industry Hub | December 12, 2024 |

AusBiotech and BioMelbourne Network have welcomed the Victorian Government’s release of its Economic Growth Statement, which highlights ‘Health Technologies and […]

More


News & Trends - MedTech & Diagnostics

Senator Ruston condemns Labor: Government under fire for failing patients

Senator Ruston condemns Labor: Government under fire for failing patients

Health Industry Hub | December 12, 2024 |

The NSW Labor and Albanese Governments are facing intense backlash as their failure to address the healthcare crisis continues to […]

More


News & Trends - MedTech & Diagnostics

Prescribed List reforms: Cost savings overshadowed by delays, errors and growing inefficiency

Prescribed List reforms overshadowed by delays, errors and growing inefficiency

Health Industry Hub | December 12, 2024 |

The release of the interim evaluation report of the Prescribed List (PL) reforms has revealed both unexpected delays in application […]

More


This content is copyright protected. Please subscribe to gain access.